Prosthetic News and Research

RSS

Prosthetic (Prosthesis) devices, such as an artificial leg, that replace a part of the body. Prostheses are typically used to replace parts lost by injury (traumatic) or missing from birth (congenital) or to supplement defective body parts. Inside the body, artificial heart valves are in common use with artificial hearts and lungs seeing less common use but under active technology development. Other medical devices and aids that can be considered prosthetics include artificial eyes, palatal obturator, gastric bands, and dentures.

Prosthetic arm controlled by imagining different movements

This design hopes to identify the memory of movement in the amputee's brain to translate to an order allowing manipulation of the device.

6 Aug 2014

Ability Dynamics announces new exclusive distribution relationship with OPC Health

Ability Dynamics, LLC an innovative developer of next-generation prosthetic devices announced a new exclusive distribution relationship with Australian based OPC Health for its flagship products the RUSH™ HiPro and the RUSH™LoPro prosthetic feet.

5 Aug 2014

Bitcoin Collect acquires medical device company, Good Vibration Shoes

Bitcoin Collect, Inc., today announced that it has discontinued its plans to develop virtual currency software, and has acquired a company with an exciting proprietary product in the medical devices industry.

26 Jul 2014

Adults with intellectual and developmental disabilities experience oral health problems

A retrospective study conducted by researchers at Tufts University School of Dental Medicine and colleagues reports that among adults with intellectual and developmental disabilities, the likelihood of having cavities decreased as the number of years receiving dental care increased.

10 Jul 2014

VA's medical inspector steps down

Dr. John Pierce, the director of the VA's medical inspector office, had served in that role since 2004, and is the fifth senior official at the VA to step down during the past six weeks. Also, stories look at how lawmakers are trying to reform the VA, and just why the VA was developed 100 years ago.

4 Jul 2014

New Brightree Document Management simplifies storing and access to reimbursement documents

Brightree, the leading provider of cloud-based clinical, billing and business management software solutions for the post-acute care industry, announced today the release of new Brightree Document Management capabilities that strengthen a home medical equipment (HME) provider's ability to protect reimbursements and respond more efficiently to additional documentation requests (ADRs).

28 Jun 2014

Researchers develop new model of neural network

A newly-developed, highly accurate representation of the way in which neurons behave when performing movements such as reaching could not only enhance understanding of the complex dynamics at work in the brain, but aid in the development of robotic limbs which are capable of more complex and natural movements.

19 Jun 2014

Researchers take step toward restoring natural, high-fidelity vision to blind people

In laboratory tests, researchers have used electrical stimulation of retinal cells to produce the same patterns of activity that occur when the retina sees a moving object. Although more work remains, this is a step toward restoring natural, high-fidelity vision to blind people, the researchers say.

6 Jun 2014

Innovative device has potential to reduce hemorrhage, save lives

Removing a malignant tumor from the head of the pancreas is a risky and demanding operation. The surgeon must carefully navigate around the stomach, the gallbladder, the bile duct, lymph nodes, and several high-pressure blood vessels.

29 May 2014

LifeBond to present LifeMesh self-fixating hernia mesh platform at MIXiii Biomed Conference

LifeBond Ltd., a leading developer of absorbable biosurgical products for tissue repair, announced today its new self-fixating hernia mesh platform, LifeMesh, which will be presented at the upcoming MIXiii Biomed Conference, to be held at the Israel Convention Center in Tel Aviv on May 20-22.

20 May 2014

FDA approves first prosthetic arm

On Friday, May 9, 2014, the U.S. Food and Drug Administration approved the first prosthetic arm developed by DEKA and funded by the Defense Advanced Research Projects Agency.

15 May 2014

Armetheon reaches agreement with FDA on SPA for final pivotal trial of tecarfarin

Armetheon, Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the final pivotal trial of tecarfarin.

29 Apr 2014

Scientists develop new circuit board modeled on human brain

The Neurogrid circuit board can simulate orders of magnitude more neurons and synapses than other brain mimics on the power it takes to run a tablet computer.

29 Apr 2014

Golden Jubilee National Hospital performs first Right Anterior Thoracotomy procedure in Scotland

The Golden Jubilee National Hospital has become the first in Scotland to carry out a pioneering, minimally invasive, heart valve replacement technique.

17 Apr 2014

Researchers develop prosthetic 'intelligent' liner to relieve pain experienced by amputees

A new device could help to relieve the pain and discomfort experienced by thousands of amputees as a result of poorly fitting replacement lower limbs. Researchers are developing a prototype of the world's first prosthetic 'intelligent' liner with integrated pressure sensors, which could be available to NHS patients in as little as three years.

16 Apr 2014

Lemelson-MIT Program announces winners of National Collegiate Student Prize Competition

The Lemelson-MIT Program today announced winners of the Lemelson-MIT National Collegiate Student Prize Competition (NCSPC), a nationwide search for the most inventive undergraduate and graduate students.

10 Apr 2014

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).

8 Apr 2014

FDA allows CryoLife to begin PerClot clinical trial in the U.S.

CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has received approval of its Investigational Device Exemption (IDE) for PerClot from the United States Food and Drug Administration.

2 Apr 2014

Experts in brain and spinal cord injuries to discuss treatment approaches at 23rd Annual Meeting of AMSSM

Post-concussion syndrome (PCS) and spinal cord injuries are complex problems that can present with a variety of symptoms or sequelae.

29 Mar 2014

Researchers find mechanism for spatial self-awareness that combines visual cues with body motion

Your brain's ability to instantly link what you see with what you do is down to a dedicated information 'highway', suggests new UCL-led research.

17 Mar 2014